RETRACTED: LncRNA TCF7 Promotes Epithelial Ovarian Cancer Viability, Mobility and Stemness via Regulating ITGB8

Su, Changlei; Huang, Kejin

doi:10.3389/fonc.2021.649655

ORIGINAL RESEARCH article

Front. Oncol. , 17 November 2021

Sec. Gynecological Oncology

Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.649655

RETRACTED: LncRNA TCF7 Promotes Epithelial Ovarian Cancer Viability, Mobility and Stemness via Regulating ITGB8

Retracted

A retraction of this article was approved in:

Retraction: LncRNA TCF7 promotes epithelial ovarian cancer viability, mobility and stemness via regulating ITGB8
1. Read retraction

Changlei Su¹

Kejin Huang^2*

¹Department of General Surgery, The Second Hospital of Harbin Medical University, Harbin, China
²Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Su C and Huang K (2021) LncRNA TCF7 Promotes Epithelial Ovarian Cancer Viability, Mobility and Stemness via Regulating ITGB8. Front. Oncol. 11:649655. doi: 10.3389/fonc.2021.649655

Received: 17 February 2021; Accepted: 22 October 2021;
Published: 17 November 2021; Retracted: 19 October 2023.

Edited by:

Robert Vierkant, Mayo Clinic, United States

Reviewed by:

Pablo Vivas-Mejia, University of Puerto Rico, Puerto Rico
Qi Yu, Peking Union Medical College Hospital (CAMS), China
Xiabin Ye, The First Affiliated Hospital of Lishui University, China
Einar Kristiansen, Oslo University Hospital, Norway

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

RETRACTED: LncRNA TCF7 Promotes Epithelial Ovarian Cancer Viability, Mobility and Stemness via Regulating ITGB8

94% of researchers rate our articles as excellent or good

94% of researchers rate our articles as excellent or good